High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case-Reference-Cited by-同舟云学术

High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case

Published:2020-09-17 Issue:5 Volume:4 Page:e471
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

D’Angiò Mariella,Fazio Grazia,Grioni Andrea,Palamini Sonia,Sala Simona,Galbiati Marta,Biondi Andrea,Balduzzi Adriana,Rizzari Carmelo,Cazzaniga Giovanni

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference15 articles.

1. EVI1 and hematopoietic disorders: history and perspectives;Nucifora;Gene.,2006

2. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia;Lugthart;J Clin Oncol.,2010

3. 3q26/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review;De Braekeleer;Future Oncol.,2015

4. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients;Barjesteh van Waalwijk van Doorn-Khosrovani;Blood.,2003

5. EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia;Balgobind;Leukemia.,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EVI1-mediated Programming of Normal and Malignant Hematopoiesis;HemaSphere;2023-10

2. 3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features;Cancers;2023-01-11

3. The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangements;HAEMATOLOGICA;2022